Jiří Lísal

Jiří Lísal graduated in biophysics at the Charles University in Prague and gained his Ph.D. in biochemistry at the University of Helsinki in Finland. From 2002 to 2006, he worked at the Institute of Biotechnology in Helsinki and then he received the Human Frontiers Science Program Long-term Fellowship allowing him to spend a two-year postdoc at the Stanford University School of Medicine in California. Jiří produced several high-impact scientific publications during those years.

In 2009 Jiří decided to move to the pharmaceutical industry. He started a new career at Zentiva which belonged to the pharmaceutical giant Sanofi at that time. At Zentiva, he was Global Project Manager and also led the pharmaceutical development department in Hlohovec Slovakia during the challenging times of its divestment. In 2014 he was appointed Research and Development Director at PRO.MED.CS, the second biggest pharmaceutical company in the Czech Republic. Jiří enjoys the challenges of streamlining and improving company processes that help bring new therapies to patients. Jiří joined SOTIO in 2019 as Chief Operating Officer.